Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

被引：0
|
作者：
Xuejie Jiang
Ling Jiang
Jiaying Cheng
Fang Chen
Jinle Ni
Changxin Yin
Qiang Wang
Zhixiang Wang
Dan Fang
Zhengshan Yi
Guopan Yu
Qingxiu Zhong
Bing Z. Carter
Fanyi Meng
机构：
[1] Nanfang Hospital,Department of Hematology
[2] Southern Medical University,Department of Hematology
[3] Kanghua Hospital,Section of Molecular Hematology and Therapy, Department of Leukemia
[4] The University of Texas MD Anderson Cancer Center,undefined
来源：
Journal of Translational Medicine | / 19卷
关键词：
EZH2; Chidamide; Leukemia; Chemosensitivity; Smo/Gli-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
    Tripathi, Brajendra K.
    Anderman, Meghan F.
    Bhargava, Disha
    Boccuzzi, Luciarita
    Qian, Xiaolan
    Wang, Dunrui
    Durkin, Marian E.
    Papageorge, Alex G.
    de Miguel, Fernando J.
    Politi, Katerina
    Walters, Kylie J.
    Doroshow, James H.
    Lowy, Douglas R.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [32] Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells
    Li, Xiaodong
    Chen, Fang
    Zhu, Qiuhua
    Ding, Bingjie
    Zhong, Qingxiu
    Huang, Kaikai
    Jiang, Xuejie
    Wang, Zhixiang
    Yin, Changxin
    Zhu, Yufeng
    Li, Zhen
    Meng, Fanyi
    ONCOTARGET, 2016, 7 (22) : 33004 - 33015
  • [33] TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2
    Li, Qun
    Song, Wei
    Wang, Jianmin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1793 - 1801
  • [34] HSA-MIR-12462 INHIBITS THE PROLIFERATION AND RESTORES THE SUSCEPTIBILITY TO CYTARABINE OF ACUTE MYELOID LEUKEMIA (AML) THROUGH INHIBITION OF GLI1
    Zeng, Hui
    Jia, Yan
    Liu, Wei
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S95 - S95
  • [35] Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
    Liang, Hui
    Zheng, Qi-Li
    Fang, Peng
    Zhang, Jian
    Zhang, Tuo
    Liu, Wei
    Guo, Min
    Robinson, Christopher L.
    Chen, Shui-bing
    Chen, Xiao-Ping
    Chen, Fang-Ping
    Zeng, Hui
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
    Hui Liang
    Qi-Li Zheng
    Peng Fang
    Jian Zhang
    Tuo Zhang
    Wei Liu
    Min Guo
    Christopher L. Robinson
    Shui-bing Chen
    Xiao-Ping Chen
    Fang-Ping Chen
    Hui Zeng
    Scientific Reports, 7
  • [37] Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3-AKT-P21-CDK2 signaling pathway
    Wang, Hao
    Liu, Yu-chen
    Zhu, Cheng-ying
    Yan, Fei
    Wang, Meng-zhen
    Chen, Xiao-su
    Wang, Xiao-kai
    Pang, Bao-xu
    Li, Yong-hui
    Liu, Dai-hong
    Gao, Chun-ji
    Liu, Shu-jun
    Dou, Li-ping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [38] Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways (vol 11, 73, 2018)
    Lian, Xiaolan
    Lin, Yu-Min
    Kozono, Shingo
    Herbert, Megan K.
    Li, Xin
    Yuan, Xiaohong
    Guo, Jiangrui
    Guo, Yafei
    Tang, Min
    Lin, Jia
    Huang, Yiping
    Wang, Bixin
    Qiu, Chenxi
    Tsai, Cheng-Yu
    Xie, Jane
    Gao, Ziang Jeff
    Wu, Yong
    Liu, Hekun
    Zhou, Xiao Zhen
    Lu, Kun Ping
    Chen, Yuanzhong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [39] Casein Kinase II Inhibitor Sensitizes the Anti-Tumor Effect of EZH2 Inhibitor By Suppressing FOSL1 Expression in Acute Myeloid Leukemia
    Yang, Chan
    Song, Chunhua
    Ge, Zheng
    BLOOD, 2023, 142
  • [40] Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway
    Wang, Ziyi
    Guo, Zhe
    Wang, Xuesong
    Liao, Haiyan
    Chai, Yan
    Wang, Ziwen
    Wang, Zhong
    CELLS, 2022, 11 (24)
12345